Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35006491)

  • 1. Synthesis and Evaluation of Radioiodine-Labeled pH (Low) Insertion Peptide Variant 7-Like Peptide as a Noninvasive Tumor Microenvironment Imaging Agent in a Mouse MDA-MB-231 Triple-Negative Breast Cancer Model.
    Wu F; Chen Y; Li D; Wang Z; Yu M
    Mol Imaging Biol; 2022 Aug; 24(4):570-579. PubMed ID: 35006491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.
    Chen Y; Su Y; Pang X; Song X; Zhao W; Yu M
    Front Oncol; 2022; 12():869260. PubMed ID: 35530359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Experimental Study on [
    Yu M; Sun Y; Yang G; Wang Z
    Mol Imaging; 2021; 2021():5565932. PubMed ID: 33746628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of MDA-MB-231 cell proliferation by pHLIP(Var7)-P1AP and SPECT imaging of MDA-MB-231 breast cancer-bearing nude mice using 125I-pHLIP(Var7)-P1AP.
    Chen YH; Yu MM; Wang ZG
    Nuklearmedizin; 2021 Jun; 60(3):240-248. PubMed ID: 33759146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.
    Yu M; Chen Y; Wang Z; Ding X
    Breast Cancer Res Treat; 2020 Apr; 180(2):379-384. PubMed ID: 32034579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Distribution and Therapeutic Efficacy of Radioiodine-Labeled pH-Low Insertion Peptide Variant 3 in a Mouse Model of Breast Cancer.
    Zhang M; Xi Y; Chen H; Hai W; Li B
    Mol Imaging; 2022; 2022():7456365. PubMed ID: 35903249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small animal PET imaging with the
    Chen Y; Song S; Sun Y; Wu F; Yang G; Wang Z; Yu M
    EJNMMI Radiopharm Chem; 2024 Apr; 9(1):33. PubMed ID: 38678139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
    Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
    Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
    Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
    Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panitumumab-DOTA-
    Facca VJ; Cai Z; Gopal NEK; Reilly RM
    Mol Pharm; 2022 Oct; 19(10):3652-3663. PubMed ID: 35926098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization Study.
    Demoin DW; Wyatt LC; Edwards KJ; Abdel-Atti D; Sarparanta M; Pourat J; Longo VA; Carlin SD; Engelman DM; Andreev OA; Reshetnyak YK; Viola-Villegas N; Lewis JS
    Bioconjug Chem; 2016 Sep; 27(9):2014-23. PubMed ID: 27396694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.
    Vorobyeva A; Bezverkhniaia E; Konovalova E; Schulga A; Garousi J; Vorontsova O; Abouzayed A; Orlova A; Deyev S; Tolmachev V
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
    Burns KE; Robinson MK; Thévenin D
    Mol Pharm; 2015 Apr; 12(4):1250-8. PubMed ID: 25741818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP).
    Svoronos AA; Engelman DM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.
    Kumar SR; Deutscher SL
    J Nucl Med; 2008 May; 49(5):796-803. PubMed ID: 18413389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of [
    Cavaliere A; Sun S; Lee S; Bodner J; Li Z; Huang Y; Moores SL; Marquez-Nostra B
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):383-394. PubMed ID: 32770372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart Design of a pH-Responsive System Based on pHLIP-Modified Magnetite Nanoparticles for Tumor MRI.
    Demin AM; Pershina AG; Minin AS; Brikunova OY; Murzakaev AM; Perekucha NA; Romashchenko AV; Shevelev OB; Uimin MA; Byzov IV; Malkeyeva D; Kiseleva E; Efimova LV; Vtorushin SV; Ogorodova LM; Krasnov VP
    ACS Appl Mater Interfaces; 2021 Aug; 13(31):36800-36815. PubMed ID: 34324807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo pH imaging with (99m)Tc-pHLIP.
    Macholl S; Morrison MS; Iveson P; Arbo BE; Andreev OA; Reshetnyak YK; Engelman DM; Johannesen E
    Mol Imaging Biol; 2012 Dec; 14(6):725-34. PubMed ID: 22371188
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.